After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...

Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Current financial screening procedures in the United States may need to change, according to recent research done by Laila ...

People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop ...

The company recently announced promising results from its phase 2a clinical of an agent that the company says is the first to target Traf2- and NCK-interacting kinase, or TNIK for short.

ICER Gives Cell Therapy for Post-Transplant Complications High Rating ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

ICER Gives Cell Therapy for Post-Transplant Complications High Rating ...

Aucatzyl is a CAR T-cell therapy that targets CD19 and has been designed to minimize excessive activation of the programmed T ...

The panelist discusses how intrauterine insemination is typically considered for patients with unexplained infertility, mild ...